Conference preview: Life Science IP Forum, London

In an interview with Legal IQ, which is hosting the Life Science IP Forum on November 27 and 28 in London, Ryan Zurek, managing director of IP merchant bank Ocean Tomo, described the life sciences IP market as “highly inefficient”.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

Mental health in IP: ‘We have a clear picture of the problem’

30 December 2025 The Life in the Law 2025 report sheds light on the mental health challenges faced by legal professionals, revealing the links between wellbeing, inclusion and modern working practices. IP Inclusive’s Andrea Brewster explores how the findings offer clear guidance for meaningful change.

Europe

From Edwards to Insulet: Three key medical device cases of 2025

29 December 2025 Edwards v Meril, Teva and the FTC, and modified jury verdicts—lawyers from WilmerHale provide a review of the key cases of the year and their implications.

Europe

Edwards v Meril: Behind the UPC’s landmark medtech showdown

24 December 2025 As Edwards secures another win against its rival, LSIPR talks to Siddharth Kusumakar—partner at Powell Gilbert and counsel for the winning party.

More features

Hogan Lovells and Cadwalader strike historic deal to create $3.6bn firm

Regeneron v Alvotech: The big impact

Beyond traditional IP: A comprehensive AI strategy for life sciences

Prosecuting bispecific antibody patents: A cookbook for patent chefs

New IP guidance promises to transform the NHS. Will it deliver?

Patent and SPC litigator makes the move from Carpmaels

EU Pharma Package hits the final stretch—but can negotiators agree?

The clinical trial dilemma: Navigating European practice

Conference preview: Life Science IP Forum, London

More on this story

Editor's picks

Editor's picks

More features